Bacteriophage compositions and methods for treatment of bacterial infections
AssigneeThe University of Chicago
InventorsMark MIMEE, Ella ROTMAN
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more isolated bacteriophage comprising a bacterio-phage sequence that is at least 99% identical to any one of SEQ ID NO:1-74. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic Klebsiella infection.
Claims21
1-153. (canceled)
A composition comprising a collection of isolated bacteriophage comprising:
- i. an Ackermannviridae bacteriophage, a Tevenvirinae bacteriophage, a Slopekvirus bacteriophage, a Siphoviridae bacteriophage, and/or a Demerecviridae bacteriophage;
- ii. an Autographiviridae bacteriophage, a Tevenvirinae bacteriophage, one or more Slopekvirus bacteriophage, and/or a Purpuraviridae bacteriophage;
- or
- iii. an Autographiviridae bacteriophage, a Tevenvirinae bacteriophage, one or more Slopekvirus bacteriophage, a Demerecviridae bacteriophage, and/or a Purpuraviridae bacteriophage.
A composition comprising at least one isolated bacteriophage comprising a bacteriophage sequence that is at least 99% identical to any one of SEQ ID NO:1-74.
A method for treating and/or preventing a Klebsiella infection in a subject comprising administering to the subject a composition comprising at least one isolated bacteriophage comprising a bacteriophage sequence that is at least 99% identical to any one of SEQ ID NO:
- 1-74.
Dependencies are inferred from the claim text.